| Bioactivity | CDD-1733 is a non-covalent and non-peptide potent SARS-CoV-2 Mpro inhibitor with a Ki of 12 nM. CDD-1733 also inhibits ΔP168, A173V, and ΔP168/A173V Mpro variants[1]. |
| Target | Ki: 12 nM (SARS-CoV-2 Mpro) |
| Name | CDD-1733 |
| CAS | 2894104-33-5 |
| Formula | C34H32F3N5O2 |
| Molar Mass | 599.65 |
| Transport | Room temperature in continental US; may vary elsewhere. |
| Storage | Please store the product under the recommended conditions in the Certificate of Analysis. |
| Reference | [1]. Ravikumar Jimmidi, et al. DNA-encoded chemical libraries yield non-covalent and non-peptidic SARS-CoV-2 main protease inhibitors. Commun Chem. 2023 Aug 4;6(1):164. |
CDD-1733
CAS: 2894104-33-5 F: C34H32F3N5O2 W: 599.65
CDD-1733 is a non-covalent and non-peptide potent SARS-CoV-2 Mpro inhibitor with a Ki of 12 nM. CDD-1733 also inhibits
Sales Email：peptidedb@qq.com
This product is for research use only, not for human use. We do not sell to patients.